Please provide your email address to receive an email when new articles are posted on . Two clinical trials have demonstrated positive results for the full range of vision IOL. Bausch + Lomb ...
enVista Envy full range of vision intraocular lens (IOL) met all primary efficacy and safety endpoints in multicenter study Results show that enVista Envy IOLs deliver excellent visual performance, ...
VAUGHAN, Ontario--(BUSINESS WIRE)-- Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that the U.S.
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Bausch + Lomb Corporation ( (BLCO)) has ...
Hosted on MSN
Bausch + Lomb announces intraocular lens recall
Bausch + Lomb has reported a “voluntary recall” of certain intraocular lenses (IOLs) on its enVista platform due to complications. This decision was made following an increase in the number of toxic ...
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that the American Journal of Ophthalmology has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results